The relevant results further demonstrated that PA-MSHA could enhance the therapeutic effects of αPD-1 in CRC by further mediating CD8+ T cell activation as well as Granzyme B expression (Figure 5I). The gene discussed is CD8A; the disease is colorectal carcinoma.